(Q40612629)

22 September 2017

title

FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells (English)

1 reference

22 September 2017

Tsuyoshi Imai

1

1 reference

22 September 2017

Souichi Adachi

2

1 reference

22 September 2017

Koichi Nishijo

3

1 reference

22 September 2017

Masatoshi Ohgushi

4

1 reference

22 September 2017

Masayuki Okada

5

1 reference

22 September 2017

Takahiro Yasumi

6

1 reference

22 September 2017

Ken-ichiro Watanabe

7

1 reference

22 September 2017

Ryuta Nishikomori

8

1 reference

22 September 2017

Tomitaka Nakayama

9

1 reference

22 September 2017

Shin Yonehara

10

1 reference

22 September 2017

Junya Toguchida

11

1 reference

22 September 2017

Tatsutoshi Nakahata

12

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

22

1 reference

22 September 2017

issue

58

1 reference

22 September 2017

page(s)

9231-9242

1 reference

Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Osteosarcomas and other cancers of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

A protein phosphatase is involved in the inhibition of histone deacetylation by sodium butyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Modulation of resistance to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Histone acetylation in chromatin structure and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Humanization of the mouse anti-Fas antibody HFE7A and crystal structure of the humanized HFE7A Fab fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Cellular stress response and apoptosis in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

The role of p53 and pRB in apoptosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Osteoblast apoptosis and bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Induction of apoptosis by cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD / Shi-scid/scid mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Histone deacetylase inhibitors as new cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Morphological and biological heterogeneity of three tumorigenic cell lines derived from a single p53-/- osteoblast-like cell line, MMC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

From bench to clinic with apoptosis-based therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Chronic oral administration of CI-994: a phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

P21-dependent g(1)arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Histone acetylation and transcriptional regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Death receptor Fas and autoimmune disease: from the original generation to therapeutic application of agonistic anti-Fas monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

The role of CD95 system in chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

7 January 2021

Chemosensitivity of solid tumor cellsin vitro is related to activation of the CD95 system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

7 January 2021

Osteosarcoma and other bone cancers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

7 January 2021

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

7 January 2021

Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

7 January 2021

FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

7 January 2021

FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207184

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207184

1 reference

Dimensions Publication ID

22 September 2017

1023157474

0 references

1 reference